These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Genome-wide approach to identify second gene targets for malignant rhabdoid tumors using high-density oligonucleotide microarrays. Takita J, Chen Y, Kato M, Ohki K, Sato Y, Ohta S, Sugita K, Nishimura R, Hoshino N, Seki M, Sanada M, Oka A, Hayashi Y, Ogawa S. Cancer Sci; 2014 Mar; 105(3):258-64. PubMed ID: 24418192 [Abstract] [Full Text] [Related]
4. Congenital anomalies and rhabdoid tumor associated with 22q11 germline deletion and somatic inactivation of the SMARCB1 tumor suppressor. Toth G, Zraly CB, Thomson TL, Jones C, Lapetino S, Muraskas J, Zhang J, Dingwall AK. Genes Chromosomes Cancer; 2011 Jun; 50(6):379-88. PubMed ID: 21412926 [Abstract] [Full Text] [Related]
5. Novel rearrangement of chromosome band 22q11.2 causing 22q11 microdeletion syndrome-like phenotype and rhabdoid tumor of the kidney. Wieser R, Fritz B, Ullmann R, Müller I, Galhuber M, Storlazzi CT, Ramaswamy A, Christiansen H, Shimizu N, Rehder H. Hum Mutat; 2005 Aug; 26(2):78-83. PubMed ID: 15957176 [Abstract] [Full Text] [Related]
6. Malignant rhabdoid tumor of the bladder and ganglioglioma in a 14 year-old male with a germline 22q11.2 deletion. Bosse KR, Shukla AR, Pawel B, Chikwava KR, Santi M, Tooke L, Castagna K, Biegel JA, Bagatell R. Cancer Genet; 2014 Sep; 207(9):415-9. PubMed ID: 25018128 [Abstract] [Full Text] [Related]
7. Chromosome 22q deletions in atypical teratoid/rhabdoid tumors in adults. Raisanen J, Biegel JA, Hatanpaa KJ, Judkins A, White CL, Perry A. Brain Pathol; 2005 Jan; 15(1):23-8. PubMed ID: 15779233 [Abstract] [Full Text] [Related]
8. High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor. Jackson EM, Shaikh TH, Gururangan S, Jones MC, Malkin D, Nikkel SM, Zuppan CW, Wainwright LM, Zhang F, Biegel JA. Hum Genet; 2007 Sep; 122(2):117-27. PubMed ID: 17541642 [Abstract] [Full Text] [Related]
9. High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors. Hasselblatt M, Isken S, Linge A, Eikmeier K, Jeibmann A, Oyen F, Nagel I, Richter J, Bartelheim K, Kordes U, Schneppenheim R, Frühwald M, Siebert R, Paulus W. Genes Chromosomes Cancer; 2013 Feb; 52(2):185-90. PubMed ID: 23074045 [Abstract] [Full Text] [Related]
10. Diagnosis of distal 22q11.2 deletion syndrome in a patient with a teratoid/rhabdoid tumour. Beddow RA, Smith M, Kidd A, Corbett R, Hunter AG. Eur J Med Genet; 2011 Feb; 54(3):295-8. PubMed ID: 21187175 [Abstract] [Full Text] [Related]
11. Rhabdoid tumor predisposition syndrome with renal tumor 10 years after brain tumor. Fukushima H, Yamasaki K, Sakaida M, Tsujio N, Okuno T, Ishii N, Okada K, Fujisaki H, Matsusaka Y, Sakamoto H, Yoneda A, Hara J, Inoue T. Pathol Int; 2021 Feb; 71(2):155-160. PubMed ID: 33378586 [Abstract] [Full Text] [Related]
12. High prevalence of SMARCB1 constitutional abnormalities including mosaicism in malignant rhabdoid tumors. Shirai R, Osumi T, Terashima K, Kiyotani C, Uchiyama M, Tsujimoto S, Yoshida M, Yoshida K, Uchiyama T, Tomizawa D, Shioda Y, Sekiguchi M, Watanabe K, Keino D, Ueno-Yokohata H, Ohki K, Takita J, Ito S, Deguchi T, Kiyokawa N, Ogiwara H, Hishiki T, Ogawa S, Okita H, Matsumoto K, Yoshioka T, Kato M. Eur J Hum Genet; 2020 Aug; 28(8):1124-1128. PubMed ID: 32218533 [Abstract] [Full Text] [Related]
13. Secondary EWSR1 gene abnormalities in SMARCB1-deficient tumors with 22q11-12 regional deletions: Potential pitfalls in interpreting EWSR1 FISH results. Huang SC, Zhang L, Sung YS, Chen CL, Kao YC, Agaram NP, Antonescu CR. Genes Chromosomes Cancer; 2016 Oct; 55(10):767-76. PubMed ID: 27218413 [Abstract] [Full Text] [Related]
14. Loss of heterozygosity at chromosome regions 22q11-12 and 11p15.5 in renal rhabdoid tumors. Schofield DE, Beckwith JB, Sklar J. Genes Chromosomes Cancer; 1996 Jan; 15(1):10-7. PubMed ID: 8824720 [Abstract] [Full Text] [Related]
15. Description of a new oncogenic mechanism for atypical teratoid rhabdoid tumors in patients with ring chromosome 22. Byers HM, Adam MP, LaCroix A, Leary SE, Cole B, Dobyns WB, Mefford HC. Am J Med Genet A; 2017 Jan; 173(1):245-249. PubMed ID: 27734605 [Abstract] [Full Text] [Related]
16. Gene of the month: SMARCB1. Kalimuthu SN, Chetty R. J Clin Pathol; 2016 Jun; 69(6):484-9. PubMed ID: 26941181 [Abstract] [Full Text] [Related]
17. Goldenhar phenotype in a child with distal 22q11.2 deletion and intracranial atypical teratoid rhabdoid tumor. Lafay-Cousin L, Payne E, Strother D, Chernos J, Chan M, Bernier FP. Am J Med Genet A; 2009 Dec; 149A(12):2855-9. PubMed ID: 19938088 [Abstract] [Full Text] [Related]
18. Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome. Frühwald MC, Hasselblatt M, Wirth S, Köhler G, Schneppenheim R, Subero JI, Siebert R, Kordes U, Jürgens H, Vormoor J. Pediatr Blood Cancer; 2006 Sep; 47(3):273-8. PubMed ID: 16206192 [Abstract] [Full Text] [Related]
19. Rhabdoid tumor predisposition syndrome caused by SMARCB1 constitutional deletion: prenatal detection of new case of recurrence in siblings due to gonadal mosaicism. Gigante L, Paganini I, Frontali M, Ciabattoni S, Sangiuolo FC, Papi L. Fam Cancer; 2016 Jan; 15(1):123-6. PubMed ID: 26342593 [Abstract] [Full Text] [Related]
20. Novel germ-line deletion of SNF5/INI1/SMARCB1 gene in neonate presenting with congenital malignant rhabdoid tumor of kidney and brain primitive neuroectodermal tumor. Kusafuka T, Miao J, Yoneda A, Kuroda S, Fukuzawa M. Genes Chromosomes Cancer; 2004 Jun; 40(2):133-9. PubMed ID: 15101046 [Abstract] [Full Text] [Related] Page: [Next] [New Search]